Merrimack Pharma-Ipsen’s Cancer Drug Fails In Overall Survival Measure
Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK) partner announced that Ipsen SA (OTC:IPSEY) reported a primary analysis of the results of the…
53 Biggest Movers From Yesterday
Gainers
MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.
32 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Exela Technologies, Inc. (NASDAQ: XELA) rose 32% to $0.7262 after the company announced a share buyback of up to 100 million shares of common stock at $1 per share through an exchange offer of new notes.
Merrimack Pharmaceuticals Q3 EPS $(0.04) Up From $(0.08) YoY
Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.04) per share. This is a 50 percent increase over losses of $(0.08) per share from the same period last year.
Merrimack Pharmaceuticals Q2 EPS $(0.06) Up From $(0.09) YoY
Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.06) per share. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year.